Florida Veteran's Stage 4 Lung Cancer Transformed by Groundbreaking Clinical Trial

A Grim Diagnosis

• 💔 Jorge Manchola, a retired Air Force Staff Sergeant, was diagnosed with stage 4 lung cancer in November 2024.
• 🧠 The cancer had spread to his lungs and brain, causing constant pain and rendering him unable to walk without a wheelchair.
• ⚠️ Manchola had an aggressive mutation called KRS G12D, which occurs in about 2% of lung cancer cases, often in non-smokers.
• ⏳ His initial prognosis was dire, with an uncertain life expectancy, and traditional chemotherapy was no longer an option.

A New Hope: Clinical Trial Breakthrough

• 🎯 Manchola was referred to Moffitt Cancer Center, where a phase one clinical trial targeting the KRS G12D mutation had just opened.
• 💊 The trial involves an oral pill called Zoldon Rasip, specifically designed to target cancer cells with this mutation.
• ✨ The drug's targeted action minimizes side effects, avoiding damage to the rest of the body.

Remarkable Recovery and Future Outlook

• ⚡ Within months of starting the trial, Manchola experienced a significant return of mobility.
• 🚴 He celebrated his recovery by completing a 100-mile bike ride in New Jersey, feeling great.
• 🗺️ Weeks later, he completed another 100-mile ride from Philadelphia to Manhattan, with plans for further endurance events.
• 📈 With hundreds of patients participating in the trial at Moffitt, the drug is nearing potential FDA approval, offering hope to more patients nationwide.